CO5570663A2 - Derivados del acido mandelico - Google Patents
Derivados del acido mandelicoInfo
- Publication number
- CO5570663A2 CO5570663A2 CO05049707A CO05049707A CO5570663A2 CO 5570663 A2 CO5570663 A2 CO 5570663A2 CO 05049707 A CO05049707 A CO 05049707A CO 05049707 A CO05049707 A CO 05049707A CO 5570663 A2 CO5570663 A2 CO 5570663A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkoxy
- alkyl
- aryl
- carbamoyl
- carbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
Abstract
1.- Compuestos de formula (I) en dondeR1 es hidrógeno, OH, NH2, alcoxiC1-7-carbonilo, aril-alcoxiC1-7-carbonilo, ariloxi-carbonilo, alquiloC1-7-carbonilo, aril-carbonilo, o alcoxiC1-7-carbonilo, que está sustituido con halógeno; R2, R3 y R4 cada uno independientemente es seleccionado del grupo consistente de hidrógeno, halógeno, hidroxi, carboxi-alquiloC1-7-NH, carbamoil-alquiloC1-7-NH, alcoxiC1-7- carbonil-alquiloC1-7-NH, hidroxi-cicloalquiloC3-10-oxi, dihidroxi-cicloalquiloC3-10-oxi, arilo, ariloxi, aril-NH, aril-alquiloC1-7-NH, aril-alquiloC1-7-SO2NH, aril-alcoxiC1-7-carbonil-NH, aril-alquiloC1-7-NH-carbonil-NH, heteroariloxi, heteroaril-alquiloC1-7-NH, y alcoxiC1-7, cuyo alcoxiC1-7 puede estar opcionalmente sustituido con hidroxi, carboxi, carbamoilo, carbamimidoilo, CF3, arilo, heteroarilo, alquiloC1-7-carbamoilo, alcoxiC1-7-carbonilo, arilo-carbamoilo, alcoxiC1-7-alquiloC1-7- carbamoilo, heterociclil-alquiloC1-7-carbamoilo, o N (alquiloC1-7)2-alquiloC1-7-carbamoilo;R5 es alquiloC1-7 o cicloalquiloC3-10, o, Si X es O o NR12, R5 también puede ser hidrógeno;R6 es hidrógeno, alquiloC1-7, o fluoro-alquiloC1-7;Y es N o C-R11;R7, R8, R9, R10 y R11 cada uno independientemente es seleccionado del grupo consistente de hidrógeno, hidroxi, halógeno, amino, alquiloC1-7-amino, di-alquiloC1-7-amino, alquiloC1-7-carbonil-amino, NO2, fluoro-alquiloC1-7, alcoxiC1-7, hidroxi-alcoxiC1-7, fluoro-alcoxiC1-7, alquinilC2-7, hidroxi-alquinilC2-7, arilo, aril-alcoxiC1-7, ariloxi, ariloxi-alcoxiC1-7, heterociclilo, heterocicliloxi, alcoxiC1-7-carbonil-alcoxiC1-7, carbamoil-alcoxiC1-7, carboxi-alcoxiC1-7, cicloalquilC3-10oxi, heteroarilo, amino-alcoxiC1-7, alquiloC1-7-amino-alcoxiC1-7, y di-alquilC1-7-amino-alcoxiC1-7, alquiloC1-7-carbonil-amino-alcoxiC1-7, HO-N=CH, HCO, fluoroalquiloC1-7-SO2-O, (alcoxiC1-7)2-4, CH(alcoxiC1-7), hidroxi-cloro-alcoxiC1-7, aril-alcoxiC1-7-alcoxiC1-7, aril-NH, aril-NH-alquiloC1-7, aril-alquiloC1-7-carbonilo-NH, heterociclil-alquiloC1-7, heterociclil-carbonilo, heterociclil-alcoxiC1-7, alquiloC1-7-carbamoilo, fluoro-alquiloC1-7-carbamoilo, cicloalquiloC3-10-carbamoilo, cicloalquiloC3-10-alquiloC1-7-carbamoilo, di-alquiloC1-7-carbamoilo, ...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02026365 | 2002-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5570663A2 true CO5570663A2 (es) | 2005-10-31 |
Family
ID=32337999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO05049707A CO5570663A2 (es) | 2002-11-25 | 2005-05-23 | Derivados del acido mandelico |
Country Status (24)
Country | Link |
---|---|
US (1) | US7129238B2 (es) |
EP (1) | EP1567498B1 (es) |
JP (1) | JP4271657B2 (es) |
KR (1) | KR100705156B1 (es) |
CN (1) | CN1714079A (es) |
AR (1) | AR042109A1 (es) |
AT (1) | ATE384696T1 (es) |
AU (1) | AU2003292072B2 (es) |
BR (1) | BR0316508A (es) |
CA (1) | CA2505542A1 (es) |
CO (1) | CO5570663A2 (es) |
DE (1) | DE60318890T2 (es) |
ES (1) | ES2298583T3 (es) |
GT (1) | GT200300252A (es) |
MX (1) | MXPA05005446A (es) |
NO (1) | NO20052311L (es) |
PA (1) | PA8589201A1 (es) |
PE (1) | PE20040696A1 (es) |
PL (1) | PL377511A1 (es) |
RU (1) | RU2005120146A (es) |
TW (1) | TW200410921A (es) |
UY (1) | UY28090A1 (es) |
WO (1) | WO2004048335A2 (es) |
ZA (1) | ZA200503989B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200410921A (en) | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
US7247654B2 (en) * | 2003-06-04 | 2007-07-24 | Bristol-Myers Squibb Company | 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors |
US7056932B2 (en) * | 2003-12-19 | 2006-06-06 | Hoffman-La Roche Inc. | Heterocyclyl substituted 1-alkoxy acetic acid amides |
UA87854C2 (en) * | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
EP1791810A1 (en) * | 2004-09-06 | 2007-06-06 | F. Hoffmann-Roche AG | 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
CA2616184A1 (en) * | 2005-08-02 | 2007-02-08 | Merck & Co., Inc. | N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
CN103641776A (zh) * | 2007-04-24 | 2014-03-19 | 日本曹达株式会社 | N-亚甲基取代甲胺多聚物的制造方法和三嗪衍生物 |
EP2650282B1 (en) | 2007-04-24 | 2017-06-07 | Nippon Soda Co., Ltd. | Process for producing substituted methylamine compound and triazine derivative |
CN104370804A (zh) * | 2007-04-24 | 2015-02-25 | 日本曹达株式会社 | 取代甲胺化合物的制造方法 |
EP2234954B1 (en) * | 2007-12-20 | 2015-02-18 | Envivo Pharmaceuticals, Inc. | Tetrasubstituted benzenes |
WO2010022148A1 (en) * | 2008-08-19 | 2010-02-25 | The Trustees Of The University Of Pennsylvania | Methods for the preparation of irciniastatin and analogs thereof |
EP2272661A1 (en) * | 2009-07-10 | 2011-01-12 | Amcor Flexibles Transpac N.V. | Packaging material with integrated pressure relief valve |
RU2545456C2 (ru) | 2010-03-12 | 2015-03-27 | Омерос Корпорейшн | Pde10 ингибиторы и содержащие их композиции и способы |
GB201006042D0 (en) | 2010-04-12 | 2010-05-26 | Givaudan Sa | Improvements in or relating to organic compounds |
CA2800521A1 (en) | 2010-05-24 | 2011-12-01 | Toa Eiyo Ltd. | Fused imidazole derivative |
CN103044176A (zh) * | 2012-12-12 | 2013-04-17 | 云南民族大学 | 一种氢气参与环醚开环制备卤代醇的高效方法 |
WO2014107277A1 (en) * | 2012-12-13 | 2014-07-10 | Glaxosmithkline Llc | Enhancer of zeste homolog 2 inhibitors |
NZ630810A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
US10100024B2 (en) | 2014-07-29 | 2018-10-16 | Evonik Degussa Gmbh | Process for the epoxidation of an olefin |
JP2018513153A (ja) | 2015-04-24 | 2018-05-24 | オメロス コーポレーション | Pde10インヒビターならびに関連する組成物および方法 |
PL3288927T3 (pl) | 2015-04-28 | 2020-03-31 | Evonik Degussa Gmbh | Sposób epoksydacji propenu |
US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
BR112018010746B1 (pt) | 2015-11-25 | 2020-10-06 | Evonik Operations Gmbh | Método para produzir propileno glicol a partir de propeno e peróxido de hidrogênio |
PL3380460T3 (pl) | 2015-11-26 | 2021-11-08 | Evonik Operations Gmbh | Sposób i reaktor epoksydacji propenu |
EP3380459B1 (en) | 2015-11-26 | 2020-01-01 | Evonik Operations GmbH | Process for the epoxidation of an olefin |
PL3380458T3 (pl) | 2015-11-26 | 2020-03-31 | Evonik Degussa Gmbh | Sposób epoksydowania propenu |
TWI707847B (zh) | 2015-11-26 | 2020-10-21 | 德商贏創運營有限公司 | 丙烯之環氧化方法 |
KR102625924B1 (ko) | 2016-01-19 | 2024-01-16 | 에보닉 오퍼레이션스 게엠베하 | 올레핀의 에폭시화 방법 |
HUE052019T2 (hu) | 2016-03-21 | 2021-04-28 | Evonik Operations Gmbh | Eljárás propén epoxidálására |
EP3246323A1 (en) | 2016-05-17 | 2017-11-22 | Evonik Degussa GmbH | Integrated process for making propene oxide from propane |
WO2018205244A1 (en) | 2017-05-12 | 2018-11-15 | Evonik Degussa Gmbh | Process for the epoxidation of propene |
EP3406603A1 (en) | 2017-05-22 | 2018-11-28 | Evonik Degussa GmbH | Process for the epoxidation of propene |
EP3438101A1 (en) | 2017-08-01 | 2019-02-06 | Evonik Degussa GmbH | Process for the epoxidation of propene |
CA3181637A1 (en) * | 2020-06-10 | 2021-12-16 | Ulf Bjorklund | Method for preparing a crystalline form of rabeximod |
CN117377662A (zh) | 2021-05-10 | 2024-01-09 | 赢创运营有限公司 | 用于制造环氧丙烷的集成设备和集成方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4128681A1 (de) * | 1991-08-29 | 1993-03-04 | Bayer Ag | Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
US6060491A (en) * | 1997-06-19 | 2000-05-09 | Dupont Pharmaceuticals | 6-membered aromatics as factor Xa inhibitors |
DE59808751D1 (de) * | 1997-12-04 | 2003-07-24 | Hoffmann La Roche | N-(4-carbamimido-phenyl)-glycinamidderivate |
US6358960B1 (en) * | 1998-02-17 | 2002-03-19 | Ono Pharmaceutical Co., Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
EP1149069B1 (en) * | 1998-12-14 | 2004-08-25 | F. Hoffmann-La Roche Ag | Phenylglycine derivatives |
AU2001243598A1 (en) * | 2000-03-13 | 2001-09-24 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
US6548694B2 (en) * | 2000-05-23 | 2003-04-15 | Hoffman-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
DE10027024A1 (de) * | 2000-05-31 | 2001-12-06 | Merck Patent Gmbh | Carbaminsäureester |
DE10037146A1 (de) * | 2000-07-29 | 2002-02-07 | Merck Patent Gmbh | Acetamidderivate |
DE10040783A1 (de) * | 2000-08-21 | 2002-03-07 | Merck Patent Gmbh | AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) |
EP1193248A1 (en) * | 2000-09-30 | 2002-04-03 | Aventis Pharma Deutschland GmbH | Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
AU2002213393B2 (en) * | 2000-10-20 | 2007-02-15 | Biocryst Pharmaceuticals, Inc. | Biaryl compounds as serine protease inhibitors |
US6713467B2 (en) * | 2000-11-07 | 2004-03-30 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
US7001887B2 (en) * | 2001-02-02 | 2006-02-21 | Chugai Seiyaku Kabushiki Kaisha | Peptide derivatives |
GB0121337D0 (en) * | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
TW200410921A (en) | 2002-11-25 | 2004-07-01 | Hoffmann La Roche | Mandelic acid derivatives |
-
2003
- 2003-11-19 TW TW092132416A patent/TW200410921A/zh unknown
- 2003-11-20 PA PA20038589201A patent/PA8589201A1/es unknown
- 2003-11-21 BR BR0316508-6A patent/BR0316508A/pt not_active IP Right Cessation
- 2003-11-21 US US10/720,790 patent/US7129238B2/en not_active Expired - Fee Related
- 2003-11-21 AU AU2003292072A patent/AU2003292072B2/en not_active Ceased
- 2003-11-21 AR ARP030104302A patent/AR042109A1/es not_active Application Discontinuation
- 2003-11-21 JP JP2004554412A patent/JP4271657B2/ja not_active Expired - Fee Related
- 2003-11-21 DE DE60318890T patent/DE60318890T2/de not_active Expired - Fee Related
- 2003-11-21 MX MXPA05005446A patent/MXPA05005446A/es active IP Right Grant
- 2003-11-21 EP EP03767602A patent/EP1567498B1/en not_active Expired - Lifetime
- 2003-11-21 AT AT03767602T patent/ATE384696T1/de not_active IP Right Cessation
- 2003-11-21 CA CA002505542A patent/CA2505542A1/en not_active Abandoned
- 2003-11-21 KR KR1020057009363A patent/KR100705156B1/ko not_active IP Right Cessation
- 2003-11-21 CN CNA2003801035506A patent/CN1714079A/zh active Pending
- 2003-11-21 RU RU2005120146/04A patent/RU2005120146A/ru not_active Application Discontinuation
- 2003-11-21 ES ES03767602T patent/ES2298583T3/es not_active Expired - Lifetime
- 2003-11-21 WO PCT/EP2003/013087 patent/WO2004048335A2/en active IP Right Grant
- 2003-11-21 PE PE2003001183A patent/PE20040696A1/es not_active Application Discontinuation
- 2003-11-21 GT GT200300252A patent/GT200300252A/es unknown
- 2003-11-21 PL PL377511A patent/PL377511A1/pl not_active Application Discontinuation
- 2003-11-24 UY UY28090A patent/UY28090A1/es not_active Application Discontinuation
-
2005
- 2005-05-11 NO NO20052311A patent/NO20052311L/no unknown
- 2005-05-17 ZA ZA200503989A patent/ZA200503989B/en unknown
- 2005-05-23 CO CO05049707A patent/CO5570663A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1567498B1 (en) | 2008-01-23 |
JP2006515284A (ja) | 2006-05-25 |
PE20040696A1 (es) | 2004-10-08 |
RU2005120146A (ru) | 2006-05-10 |
PA8589201A1 (es) | 2004-07-26 |
AU2003292072B2 (en) | 2006-12-07 |
DE60318890T2 (de) | 2009-01-15 |
AR042109A1 (es) | 2005-06-08 |
WO2004048335A3 (en) | 2004-08-19 |
DE60318890D1 (de) | 2008-03-13 |
EP1567498A2 (en) | 2005-08-31 |
GT200300252A (es) | 2004-06-28 |
ES2298583T3 (es) | 2008-05-16 |
AU2003292072A1 (en) | 2004-06-18 |
TW200410921A (en) | 2004-07-01 |
ATE384696T1 (de) | 2008-02-15 |
ZA200503989B (en) | 2006-12-27 |
KR20050086774A (ko) | 2005-08-30 |
CN1714079A (zh) | 2005-12-28 |
KR100705156B1 (ko) | 2007-04-09 |
UY28090A1 (es) | 2004-05-31 |
US20040122057A1 (en) | 2004-06-24 |
PL377511A1 (pl) | 2006-02-06 |
WO2004048335A2 (en) | 2004-06-10 |
BR0316508A (pt) | 2005-10-04 |
JP4271657B2 (ja) | 2009-06-03 |
NO20052311L (no) | 2005-06-16 |
MXPA05005446A (es) | 2005-08-26 |
US7129238B2 (en) | 2006-10-31 |
CA2505542A1 (en) | 2004-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5570663A2 (es) | Derivados del acido mandelico | |
ATE477254T1 (de) | Pyrrolidine als inhibitoren von iap | |
ATE453639T1 (de) | Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer | |
CO5640118A2 (es) | 5,7-diaminopirazol[4,3-d]piridinas utiles en el tratamiento de la hipertension | |
PE20070808A1 (es) | COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA | |
CO5550462A2 (es) | Derivados de dolastatina 10 | |
PE20110059A1 (es) | Isoquinolinas e isoquinolinonas sustituidas en calidad de inhibidores de la rho-quinasa | |
TW200745116A (en) | Macrocylic inhibitors of hepatitis C virus | |
DE602006012801D1 (de) | Verwendung von 1- benzyl-1- hydroxy-2, 3-diamino-propylaminen, 3-benzyl-3 hydroxy-2-amino-propionsäureamiden und verwandten verbindungen als analgetika | |
IN2012DN04853A (es) | ||
AR040349A1 (es) | Quinolinas sustituidas como antagonistas del receptor ccr5 | |
GEP20125456B (en) | Azetidines as mek inhibitors for the treatment of proliferative diseases | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
PE20070217A1 (es) | Derivados de isoquinolona sustituidos con piperidinilo | |
MXPA05009059A (es) | Derivados de heteroarilcarbamoilbenceno. | |
PE20071321A1 (es) | Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados | |
MY135309A (en) | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors | |
TW201129553A (en) | Dipeptidyl peptidase inhibitors | |
AR034985A1 (es) | Compuesto biciclico; produccion y uso del mismo | |
DE60234028D1 (de) | Hydantion-derivate als hemmer von matrix-metalloproteinasen | |
CY1107846T1 (el) | Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες | |
AR054482A1 (es) | Derivados de azetidinona para el tratamiento de hiperlipidemias | |
PE20070352A1 (es) | Compuestos de imidazol sustituidos como inhibidores de ksp | |
MX2014001023A (es) | Derivados de quinazolina. | |
MXPA04004501A (es) | Derivados de 4-4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o sales de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |